Patent intelligence · AU
AU 2007271920
Benzyl amines, a process for their production and their use as anti-inflammatory agents
Benzyl amines, a process for their production and their use as anti-inflammatory agents
Patent details — AU 2007271920
- Jurisdiction
- AU
- Status
- granted
- Grant date
- Jan 17, 2008
- Expiration
- Jan 12, 2028
- Applicant
- BAYER SCHERING PHARMA AG [SE]
- CPC classes
- A61K 31/ 136 A I, A61P/100, A61P/104, A61P/1100
Quick answer
AU 2007271920 (Benzyl amines, a process for their production and their use as anti-inflammatory agents) is held by BAYER SCHERING PHARMA AG [SE]. Status: granted. Granted Jan 17, 2008. Expires Jan 12, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BAYER SCHERING PHARMA AG [SE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 136 A I, A61P/100, A61P/104, A61P/1100, A61P/1106, A61P/116
More from BAYER SCHERING PHARMA AG [SE]
Related pharmaceutical patents in our USPTO index.
-
IL 240179
Use of a monoclonal, chimeric, human antibody that binds il-5r in the manufacture of a medicament for reducing the numbers of blood basophils in a human subject
granted -
ZA 201308176
THERAPEUTIC TREATMENT
granted -
SI 2158199
PIPERIDINE COMPOUNDS AND USES THEREOF
granted -
US 2010280048
Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
granted -
DO P2009000148
DERIVADOS DE ESTER Y AMIDA DE INDAZOLILO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR UN RECEPTOR DE GLUCOCORTICOIDES
granted -
EP 2086964
BENZOYLAMINOHETEROCYCLYLVERBINDUNGEN, DIE SICH FÜR DIE BEHANDLUNG EINER DURCH GLK VERMITTELTEN KRANKHEIT EIGNEN
granted -
EP 2079730
MGLUR5-MODULATOREN
granted -
EP 2064340
VERFAHREN ZUR BEWERTUNG VON PATIENTEN BEI DER BEHANDLUNG MIT AUF RET-REZEPTOR-TYROSINKINASE ABZIELENDEN ARZNEISTOFFEN
granted
Frequently asked questions
What is US patent 2007271920?
AU 2007271920 (Benzyl amines, a process for their production and their use as anti-inflammatory agents) is held by BAYER SCHERING PHARMA AG [SE]. Status: granted. Granted Jan 17, 2008. Expires Jan 12, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 2007271920?
BAYER SCHERING PHARMA AG [SE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does AU 2007271920 expire?
Our index shows an expiration date of Jan 12, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.